Navigation Links
GENova gains access to Big Pharma
Date:9/15/2009

About Bridge BioResearch

Bridge BioResearch is a drug discovery company with the sole corporate focus on Obesity, Type 2 Diabetes and related metabolic disorders. It has research cooperation agreements with leading Research and Development Services providers and bioscience research institutions and universities throughout Asia and Europe. The company uses a cost-efficient technology and patent acquisition strategy for proprietary intellectual property from identified companies, government institutions and universities, paid via milestone-dependent research collaborations and grants. To learn more about Bridge BioResearch, visit www.bridgebioresearch.com.

About GENova Biotherapeutics Inc.

GENova is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen , Myriad Genetics, Medarex, and Biogen Idec. Visit GENova online at www.genovabio.com.

Forward Looking Statements

This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual re
'/>"/>

SOURCE GENova Biotherapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GENova names Aaron Whiteman as CEO
2. GENova names Dr. John Savin as Vice President
3. Genova files patent for new prostate cancer treatment
4. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
5. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
6. GENova appoints Director of Asian business development
7. GENova files patent for new breast cancer treatment
8. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
9. GENova issues clarifying press release
10. GENova appoints Dr. Philip Gould to Scientific Advisory Board
11. GENova appoints Dr. Wang Chong to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Visiting Nurse Association of Northern New Jersey ... the Way, Brightening the Day, on Friday, May 1, ... Morristown, NJ. , Guests will enjoy an elegant ... delightful cuisine, an extensive silent auction and heart-warming testimony ... awards will be presented to this year’s honorees. ...
(Date:3/26/2015)... Capistrano, Calif. (PRWEB) March 26, 2015 ... and repairs, is pleased to be featured on Innovations ... Channel on March 18, 2015. The episode will ... it is live on the Pacific Medical home page ... face life threatening emergencies, it is reassuring to trust ...
(Date:3/26/2015)... Silver Spring, Md. (PRWEB) March 26, 2015 ... (PHA) fully supports the Patients’ Access to Treatments ... of Representatives this week by Reps. David B. ... bi-partisan legislation will limit cost-sharing requirements for medications ... medications more accessible by reducing patients’ out-of-pocket expenses. ...
(Date:3/26/2015)... March 26, 2015 Leading nutritional ... state-of-the-art company website: http://www.metabolicnutrition.com . The ... website creates a user-friendly experience for consumers seeking ... , The new, enhanced Metabolic Nutrition website includes: ... the company’s diverse line of products, conveniently broken ...
(Date:3/26/2015)... 26, 2015 The beauty industry united ... a man who revolutionized the business of beauty education. ... Passage; founder of Pivot Point International, Inc. Passage’s wife ... of Leo. Held at the Art Institute of Chicago, ... of industry and media leaders and served as the ...
Breaking Medicine News(10 mins):Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2Health News:Pacific Medical Featured on the Discovery Channel 2Health News:Pacific Medical Featured on the Discovery Channel 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:Metabolic Nutrition Launches Sleek New Website with New Features and Enhanced Consumer Information 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 2Health News:#BeautyChangesLives Legacy Award Pays Tribute to Industry Icon Leo Passage 3
... mother, researchers find , , THURSDAY, Dec. 4 (HealthDay News) ... the fetus and produce immune cells that prevent the ... , This finding shows that the two coexist by ... antigens and could lead to new techniques in stem ...
... to 2007, report shows , , THURSDAY, Dec. 4 (HealthDay ... between 2000 and 2007, according to a new report, ... an international campaign to increase measles vaccination rates is ... Control and Prevention report, the number of deaths fell ...
... a,Service provider, reports they have seen a 161% increase in ... retail clients.,Attempted attacks increased from an average of 56,000 per ... to 133,000 per client per month for the last,five months. ... major,retail corporations located across the country. , ...
... economic distress and plenty, ninety percent of Americans pray, more than ... big thingsto stay healthy, to keep our jobs, and to strengthen ... and missing items. Some of us are sure God exists and ... Brandeis study published in the current issue of Poetics ...
... Dec. 4, 2008 Use of the drug ... progression of liver disease associated with the hepatitis C ... their colleagues from nine other institutions have found in ... called the HALT-C (Hepatitis C Antiviral Long-Term Treatment Against ...
... A third of Americans with diabetes do not know ... prediabetic conditions are unaware that they are at risk. ... clinical tool to identify those at highest risk for ... diabetes. If these conditions are identified early, patients may ...
Cached Medicine News:Health News:Mom's Cells Prime Fetal Immune System 2Health News:Mom's Cells Prime Fetal Immune System 3Health News:Worldwide Measles Deaths Drop Dramatically 2Health News:Worldwide Measles Deaths Drop Dramatically 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 2Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 3Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 4Health News:Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks 5Health News:A book of common prayers 2Health News:HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective 2Health News:Researcher develops screening tool to identify patients with prediabetes 2
(Date:3/26/2015)... OAK, Mich. , March 26, 2015 ... have performed the Midwest,s first commercial implant of ... Administration for patients with non-valvular atrial fibrillation. The Watchman ... long-term use of blood-thinning warfarin medication to reduce the ... most common heart rhythm disorder affecting more than 5 ...
(Date:3/26/2015)... -- CCS Medical ("CCS"), one of the nation,s leading ... chronic conditions, has named Rodney Carson ... 23.  Mr. Carson joins CCS from MDLIVE, the ... of Operations. Prior to MDLIVE, ... of Operations at NationsHealth, (n/k/a Convey Health Solutions), ...
(Date:3/26/2015)... , March 26, 2015 ... announced the addition of the "Global Smart ... report to their offering.      (Logo: ... Wearable Healthcare Devices and Services market to grow ... 2015-2019 The report covers the present ...
Breaking Medicine Technology:Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 2Beaumont Hospital, Royal Oak among first to offer alternative to blood-thinning medications for atrial fibrillation 3CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2
... NEW YORK and HOBOKEN, N.J., Jan. 18, 2011 ... second grant recipient of the Octapharma 25th Anniversary ... at The Mount Sinai Medical Center . The ... on human protein therapies in hematology, immune therapy, intensive ...
... MINNEAPOLIS, Jan. 18, 2011 Zyga Technology, Inc. ... Administration (FDA) has granted the company 510(K) clearance ...  The SImmetry Sacroiliac Joint Fusion System is intended ... joint disruptions. The SImmetry Sacroiliac Joint Fusion System ...
Cached Medicine Technology:Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center 2Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center 3Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center 4Zyga Technology, Inc. Receives FDA 510(K) Clearance for the SImmetry™ Sacroiliac Joint Fusion System 2
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
Greenberg universal retractor case, with four compartments to hold various components....
Length 6 (152 mm). Greenberg Retractor Kit is supplied with two primary bars. Primary bars attach to skull clamp....
Budde tapered retractor blade set....
Medicine Products: